Comparison of trucut biopsy and postoperative specimens histopathological diagnosis of palpable breast lesions
Dr. Mayuri Santoki, Dr. Rutvika Sutariya, Dr. Jignasa Bhalodia and Dr. Devanshi B Patel
Background: A palpable breast lump is a common clinical problem that presents to OPD. Many diagnostic modalities are available for the evaluation of breast lumps. For several years, fine needle aspiration cytology (FNAC) was the most practiced method for pathological diagnosis. However, the introduction of Trucut biopsy has resulted in many surgeons switching to Trucut biopsy since it provides enough tissue for pathologists to make an accurate diagnosis. Thus, Trucut biopsy is an important investigation for palpable breast lesions and helps in deciding subsequent treatment.
Aims and Objectives: This research aimed to define the reliability of histopathological diagnosis of Trucut biopsy and subsequent excision biopsy of palpable breast lesions.
Materials and Methods: This is a retrospective study of the breast specimens received over a period of 1 year from January 2023 to December 2023 in the histopathology division of our tertiary care hospital.
Statistical analysis: Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value, and Diagnostic Accuracy were found.
Results: Out of 46 patients of trucut biopsy histopathological diagnosis showed 14 cases (30.45%) to be benign lesions, and 32 (69.55%) as malignant lesions. There were 2 discordant and 44 concordant cases. Sensitivity, Specificity, Positive predictive value, Negative Predictive Value, and Accuracy were 94.1%, 100%, 100%, 85.7% and 95.7% respectively.
Conclusion: Thus, trucut biopsy should be considered as a first line of tissue diagnosis in a patient with a breast lump before definitive treatments.
